A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial smaller dose. Study participants took 50 mg of the medication twice daily for 10 days, hoping to treat mild-to-moderate COVID-19 symptoms. A…  read on >  read on >

As men and women enter their golden years, those who regularly fail to get a good night’s sleep face a higher risk for developing not one but two serious chronic illnesses at the same time, new research shows. Researchers from France, Finland and United Kingdom tracked the self-reported sleep routines and health status of nearly…  read on >  read on >

Dental coverage under Medicare could soon start expanding for seniors under a new proposal from the U.S. Centers for Medicare and Medicaid Services (CMS). Still, the proposed rules would not provide full coverage for regular dental care, which has been explicitly excluded from Medicare since the program’s founding in 1965. “Traditional Medicare doesn’t cover routine…  read on >  read on >

Abbott Inc. has announced that it is again recalling some of its infant formula products, though the company said this latest recall is small and should not significantly impact nationwide supply. This recall was triggered by the fact that some bottles may have defective caps that could lead to the product spoiling, which could lead…  read on >  read on >

The COVID-19 antiviral Paxlovid has been a game-changer in the global pandemic, shielding high-risk patients from the coronavirus’ most devastating effects. But Paxlovid can itself pose a risk for people taking widely prescribed heart medications to lower cholesterol, prevent blood clots or manage irregular heartbeat, a new paper warns. Some heart patients might need to…  read on >  read on >